A March 2012 report from RNCOS (an industry research firm) forecasts the global nanotechnology market to reach $26 billion by the end of 2014—representing a CAGR of roughly 19%—driven by expansion of nanomaterials, nanofilms, and nanodevices in all sectors of the economy, including throughout the built environment. 

At present, the U.S. remains the largest market for nanotechnology, although many other nations (Brazil, India, and China included) are making sizable investments in R&D for this field. In less than a decade (since the 21^st Century Nanotechnology R&D Act was signed into law on December 3, 2003), the U.S. has spent $24 billion on nanotech R&D. 

Since we first initiated coverage on Unilife (UNIS-NASDAQ) in 2009, we have seen the company grow and accomplish a number of impressive milestones. Unilife has transitioned from a development-stage Australian medical device company to a sizable, commercial-stage, NASDAQ-listed U.S. company.

Neonode Inc. (NEON.OB) is set to report fourth quarter and year-end 2011 financials on Tuesday, March 13, 2012. In anticipation of those results, now is a good time to take a closer look at the Company and its prospects. Crystal Research has initiated coverage on Neonode with the publication of a 52-page Executive Informational Overview® providing a comprehensive discussion of the Company, its technology, markets, and competitors. The report is complimentary to our readers.

Yesterday, we released a Quarterly Update on Applied DNA Sciences, Inc. (APDN-OTC), which includes an overview of the Company's first quarter FY 2012 financial results as well as a business update.